COVID-19 pandemic reduced breast, cervical, colorectal cancer screenings by millions in 2020, study finds
New findings show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018. The study is the first of its kind to evaluate the impact of the COVID-19 pandemic on cancer screenings nationally using population-based data.
Materials provided by American Cancer Society. Note: Content may be edited for style and length.
Source link aaaaa